Mitochondrial DNA (mtDNA) is like a complex puzzle: it's circular, present in multiple copies, and can contain both healthy and mutated molecules. This makes it difficult to analyze, especially for diagnosing diseases. Thanks to Next-Generation Sequencing (NGS), however, diagnosis has become more accurate. But with so much data, interpreting variants is not easy. That's why specialized bioinformatics tools, like Mitopore and MitoSAlt, are needed. These tools, tested on patients with variants or large deletions, have shown high sensitivity and accuracy. Using them together offers a huge advantage over traditional methods, also reducing computation time. In short, technology helps us understand our mitochondrial DNA better!
Mitochondrial DNA (mtDNA) is unique for several reasons: it's circular, present in multiple copies within each cell, and can contain both wild-type and mutated molecules, a phenomenon called heteroplasmy. Additionally, there are segments of nuclear DNA that resemble mitochondrial DNA, called NUMTs, which can complicate analysis. Next-Generation Sequencing (NGS) has revolutionized the diagnosis of mtDNA-related diseases, but interpreting the data is complex. Tools like Mitopore and MitoSAlt have been optimized for short- and long-read sequencing data. Mitopore is particularly effective in detecting large-scale rearrangements, while MitoSAlt excels in identifying single nucleotide variants. Both tools have been tested on patients with previous diagnoses, demonstrating high sensitivity and specificity. The combined use of these tools not only improves diagnostic accuracy but also reduces processing time, making diagnosis more efficient and precise.
